Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

Senegal institute wins $50 mln in boost to Africa’s vaccine capacity

Senegal institute wins $50 mln in boost to Africa’s vaccine capacity

NATALIE GROVER and NELLIE PEYTON THE Coalition for Epidemic Preparedness (CEPI) will invest up to $50 million over 10 years to help Senegal's Institut Pasteur expand Africa's ability to produce vaccines at scale, it said. The deal - which will also reserve the capacity to produce vaccines specifically for Global South countries during future outbreaks of disease - will help Africa take charge of its own health security, said CEPI CEO Richard Hatchett. The funds, which will initially include up to $15 million over three years, will support the development of the institute's manufacturing facilities for routine and outbreak vaccinations.…
Read More
South Africa’s Biovac in talks to manufacture COVID-19 vaccines

South Africa’s Biovac in talks to manufacture COVID-19 vaccines

WENDELL ROELF and ALEXANDER WINNING A South African company part-owned by the government is in talks with the global COVID-19 vaccine distribution scheme and pharmaceutical companies to produce some of the vaccines the country needs to protect itself against the disease. The Biovac Institute, a Cape Town-based joint venture between the government and private sector, could produce up to 30 million doses of COVID-19 vaccines per year, depending on the technology involved, Chief Executive Morena Makhoana told Reuters. Depending on whether the vaccines require a one- or two-dose regimen, that could be enough for a quarter or half of South…
Read More